City National Bank’s Kite Pharma, Inc. KITE Stock Holding History

City National Bank’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$4.79M	Sell	86,103 -72,430	-46%	-$4.56M	0.04%	260
2015 Q2	$9.67M	Buy	158,533 +117,273	+284%	+$6.69M	0.08%	208
2015 Q1	$2.38M	Buy	41,260 +1,260	+3%	+$84.4K	0.02%	362
2014 Q4	$2.31M	Buy	40,000 +20,000	+100%	+$842K	0.02%	362
2014 Q3	$570K	Buy	+20,000	New	+$495K	0.01%	627

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

City National Bank's KITE Position: Q3 2015 in Review

City National Bank reduced its Kite Pharma, Inc. (KITE) stake by 46% in Q3 2015, selling an estimated $4.56M and leaving 86,103 shares worth $4.79M. The position accounts for 0.04% of the portfolio, ranked #260.

City National Bank first reported a position in KITE in Q3 2014 and has held it in 5 quarters since. The position peaked at $9.67M in Q2 2015. 155 funds tracked by Wall St. Rank hold KITE as of Q3 2015.

City National Bank held 86,103 shares of Kite Pharma, Inc. worth $4.79M as of Q3 2015.
City National Bank sold 72,430 Kite Pharma, Inc. shares in Q3 2015, an estimated $4.56M.
Kite Pharma, Inc. made up 0.04% of City National Bank's portfolio in Q3 2015, its #260 holding.
City National Bank first reported a position in Kite Pharma, Inc. in Q3 2014 and has held it in 5 quarters since.
City National Bank's Kite Pharma, Inc. position peaked at $9.67M in Q2 2015.
155 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.